← Back to Search

Behavioral Intervention

Technology-Assisted Conscientiousness Therapy for Multiple Sclerosis (TACT-MS Trial)

N/A

Waitlist Available

Research Sponsored by State University of New York at Buffalo

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline only

Awards & highlights

TACT-MS Trial Summary

This trial examines whether a phone app can help people be more conscientious with their health, and potentially improve employment outcomes.

Who is the study for?

This trial is for adults over 18 with Multiple Sclerosis (MS) who are currently working and have a low score on the NEO-FFI Conscientiousness test, indicating less conscientious behavior than average. People with substance abuse issues, psychiatric disorders, or neurological diseases other than MS cannot participate.Check my eligibility

What is being tested?

The study is testing a phone app designed to improve health management and work life for people with MS by boosting their conscientiousness—a personality trait linked to responsible and organized behavior.See study design

What are the potential side effects?

Since this intervention involves using an app rather than medication, traditional side effects are not expected. However, users may experience stress or frustration if they find it challenging to engage with the technology or adhere to its recommendations.

TACT-MS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline, week 12, and week 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline, week 12, and week 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, week 12, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Buffalo Vocational Monitoring Survey (BVMS): change from baseline to 12 weeks and from baseline to 24 weeks

Self -Reflection and Insight Scale (SRIS): change from baseline to 12 weeks and from baseline to 24 weeks

The Valued Living Questionnaire (VLQ): change from baseline to 12 weeks and from baseline to 24 weeks

Secondary outcome measures

Beck Anxiety Inventory (BAI): change from baseline to 12 weeks and from baseline to 24 weeks

Beck Depression Inventory 2nd Edition (BDI-II): change from baseline to 12 weeks and from baseline to 24 weeks

Multiple Sclerosis

+5 more

TACT-MS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Group II: Waitlist ControlActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

State University of New York at BuffaloLead Sponsor

246 Previous Clinical Trials

49,428 Total Patients Enrolled

11 Trials studying Multiple Sclerosis

3,236 Patients Enrolled for Multiple Sclerosis

Media Library

Conscientiousness Coach (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04953689 — N/A

Multiple Sclerosis Research Study Groups: Intervention, Waitlist Control

Multiple Sclerosis Clinical Trial 2023: Conscientiousness Coach Highlights & Side Effects. Trial Name: NCT04953689 — N/A

Conscientiousness Coach (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04953689 — N/A

Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT04953689 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What primary goals does this research endeavor seek to achieve?

"The primary objective of this clinical trial is to assess the efficacy of the treatment using the Buffalo Vocational Monitoring Survey (BVMS) at baseline, Week 12, and Week 24. The secondary objectives include measuring work-related problems in multiple sclerosis patients with Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23), quantifying depression symptoms with Beck Depression Inventory 2nd Edition (BDI-II), and testing visual/spatial memory with Brief Visuospatial Memory Test Revised (BVMTR)."

Answered by AI

Is the recruitment phase of this medical experiment ongoing?

"Affirmative, the information from clinicaltrials.gov declares that this experiment is actively searching for volunteers. Initially posted on October 19th 2021 and recently edited on March 2nd 2022, it requires 60 participants across 1 research centre to be recruited."

Answered by AI

How many participants are being included in this research study?

"Affirmative. According to the records hosted on clinicaltrials.gov, this medical trial is actively recruiting patients since its initial post date of October 19th 2021 and last update from March 2nd 2022. Sixty individuals are expected for enrolment at a single site."

Answered by AI